Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Subscribe to see Kincell Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kincell Bio is a biotech company headquartered in United States. Xcout tracks 13 named people at Kincell Bio, including Larry Pitcher (Chief Executive Officer). Xcout recorded 19 job postings from Kincell Bio in the last 90 days.
7 more named people on record for Kincell Bio, with roles, board committees and tenure — see the full roster →
Xcout recorded 19 job postings from Kincell Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Kincell Bio's hiring signals →
A few of Kincell Bio's closest competitors — see the full list of competitors and alternatives →
Shanghai OBiO Technology (Group) Corp., Ltd. is a biotechnology contract development and manufacturing organization (CDMO/CRO) focused on gene and cell therapy services, including viral-vector development and manufacturing. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations developing gene-therapy and related biologics products.
Shanghai OPM Biosciences Co., Ltd. provides high-performance cell culture media, custom media development, and end-to-end CRDMO and CRO services for biopharmaceutical and biologics companies. Its offerings support clients across the drug R&D lifecycle, from early discovery and cell line development through clinical and commercial manufacturing.
MDVerse Inc. provides a software, analytics, and generative AI platform designed to support the advanced therapy medicinal products (ATMP) ecosystem. The company integrates drug creators, pharmaceutical companies, contract manufacturers, and clinical sites to streamline the supply chain, manufacturing, and delivery of precision cell and gene therapies.
Quotient Limited provides business proposal and estimate software applications for creating client documents and managing billing workflows.
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Syngene International is a contract research, development, and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services for small molecules, biologics, and other therapeutic modalities. It serves clients in the pharmaceutical, biotechnology, nutrition, animal health, and agrochemical industries by supporting their research and commercial production needs.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kincell Bio? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.